Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,886 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,267
Ph III recruiting: 131
Growth YoY: +4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,374)

clinicaltrialsPublishedShowing 301–350 of 483 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03767751	A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma	unknown	Phase 1 / Phase 2	80	Chinese PLA General HospitalOTHER	1	Dec 7, 2018	clinicaltrials
NCT03346642	Two Stage Study of Combination of Chemotherapy, SHR-1210 and/or Decitabine for Relapsed/Refractory PMBCLs	unknown	Phase 1 / Phase 2	30	Chinese PLA General HospitalOTHER	1	Dec 3, 2018